Items for Systematic Reviews and Meta-Analysis (PRISMA) guidelines are not commonly used in neurobiology and have not been previously used to estimate the size of the effect of oxytocin on feeding and its possible moderators. This systematic method offers benefits such as reproducibility, accountability of the search methods used and quantitative precision in the measurement of effect size across different samples.
14 De Vries et al. 15 therefore adapted similar guidelines for systematic reviews of animal intervention studies aiming to bring these same benefits in methodical rigor to animal research.
The present study aimed to use this rigorous methodology to synthesise the effects of oxytocin on feeding. We used PRISMA guidelines to identify all original published and unpublished experiments testing the effects of exogenous oxytocin on energy intake in wild-type animals and in humans, where oxytocin was administered in the absence of other active drugs or surgeries. Subsequently, we identified subsets of experimental designs conducive to synthesis by quantitative meta-analysis. We also aimed to identify relevant moderators of the effects of oxytocin on feeding to clarify the conditions under which these anorexigenic effects hold.
| ME THODS

| Search strategy and eligibility criteria
Two of the researchers in the present study conducted a systematic literature search to identify original studies that had administered exogenous oxytocin to either animals or humans and compared its effects on energy intake with a placebo condition. This search was conducted in accordance with PRISMA guidelines. 14 Reporting guidelines suggested by de Vries et al. 15 were followed for preclinical intervention studies with respect to the data extraction and reporting methods described below.
The search terms included in the literature search were: "oxytocin" AND ("feed*" OR "food" OR "eat" OR "consum*" OR "intake" OR "hunger" OR "satiety" OR "appetite" OR "meal"). The eligibility criteria for studies included in the systematic review were:
Inclusion criteria:
• Original experiment.
• Independent variable: Administration of exogenous oxytocin compared to placebo.
• Dependent variable: Quantity of food or nutritive substance consumed.
• Oxytocin administered in isolation from any other drug or neural stimulation.
• Article available in English.
• Neurologically typical participants (eg, participants with PraderWilli syndrome were excluded).
Exclusion criteria:
• Studies testing consumption of alcohol/ethanol or methamphetamines.
• Studies testing consumption of plain water, saccharin, or sodium solutions.
• Studies of breastfeeding neonates.
• Studies measuring the effect of oxytocin on conditioned taste aversion.
In March 2016, these terms were included in a title or topic search in the Web of Science (Core Collection) and in a text word search in
PubMed. In November 2016, these same search terms were entered into a literature search using the following Ovid resources:
International Pharmaceutical Abstracts, Ovid MEDLINE(R) The first author then proceeded to screen the reference lists of relevant reviews aiming to identify articles not included in the main search results, and independently contacted authors known to have unpublished eligible studies (identified through individual correspondence, conference attendance, and reference to an unpublished data within a published paper). In March 2017, the second author repeated the literature search among the same databases.
The first and second authors discussed discrepancies among the identified search results until a consensus regarding the eligibility of each article was reached. The literature search was once again updated using the same databases in July 2017. Basic study characteristics (including sample information, dose of oxytocin administration and duration of feeding measurement) and a qualitative summary of the findings of each experiment were extracted by a single author.
| Meta-regression
Given the wide variety of studies identified by the systematic literature search, we opted to conduct five separate meta-regressions aiming to maximise the homogeneity within each analysis. The five meta-regressions were then conducted amongst each of the following sets of experiment: (i) single-dose animal studies measuring feeding over one hour after a central injection of oxytocin; (ii) singledose animal studies measuring feeding over one hour after systemic administration of oxytocin; (iii) chronic-dosing animal studies administering central injections of oxytocin; (iv) chronic-dosing animal studies administering systemic injections of oxytocin; and (v) human studies. Effect size data (including raw means and SD or SE) and sample sizes for each study were necessary for each eligible study to be included in a meta-regression. These data were extracted by a single author directly from tables or text within the paper in cases where they were reported. For papers in which these data were not reported, the authors of the paper were contacted with a request for this information via e-mail, or via Research Gate where a current valid e-mail address was unavailable. Where these data were unavailable, the eligible paper has been described in the results of the systematic review but was omitted from the meta-regression by necessity.
Because not all of the studies identified in original systematic review were eligible for inclusion in one of these meta-regressions, the full findings of each study included in the systematic review have been reported in separate tables. The moderating and mediating factors influencing the effects of oxytocin on energy intake have been summarised in a qualitative synthesis, which follows the quantitative results reported below.
Each meta-regression was conducted as a random-effects multi-level analysis with autoregressive structure, where the second-level corresponded to a specific sample of test subjects.
The results of the meta-regression are reported in terms of the standardised mean difference between placebo and oxytocin conditions. The meta-regressions were conducted using the escalc and rma.mv commands in the metafor package for r. 16 The forest plots and bias plots were generated using comprehensive meta-analysis (cma) software (https://www.meta-analysis.com). In 4 experiments within the meta-analysis for human studies, the within-subject correlation was not available. The average within-subject correlation for human studies (0.61) was therefore imputed for these experiments.
| RE SULTS
| Systematic review
The quantity of papers identified and screened at each step of the PRISMA process during the original systematic literature search is presented in Figure 1 . Two additional unique papers were identified through the updated literature search, and one additional paper was identified through author correspondence. The original (Table S1 ). Eighteen papers included at least 1 experiment that administered a chronic dose of oxytocin. The 56 experiments measuring the effects of chronic oxytocin dosing on feeding are summarised in the Supporting information (Table S2 ).
| Meta-regression
| Acute central animal studies
We first conducted the meta-regression for the studies that administered oxytocin centrally, entering moderators for Dose and Body
Mass. Because all animals were male and housed individually, we did not include moderators for gender or socialisation. The Cook's plot generated by this analysis revealed that 1 study by Arletti et al. 
| Acute systemic animal studies
We next repeated the analysis for studies administering a single dose of systemic oxytocin including moderation analyses for Sex (QE 24 = 187.81, P < .001); Body Mass (QE 24 = 131.74, P < .001).
| Chronic central animal studies
For the meta-regression of animal studies administering repeated central injections of oxytocin, we entered the following moderators:
Gender, Dose, Body Mass and Duration of Oxytocin Administration.
The quantity of energy intake on the final day of feeding measurement was compared between oxytocin and placebo conditions. Data were drawn from 20 experiments with a total of 349 observations.
Because all animals were housed alone, socialisation was not in- Table 1 .
| Chronic systemic animal studies
The same analysis was then repeated for animal studies that admin- Table 2 .
| Human studies
The meta-regression for human studies included 21 experiments with a total of 1020 observations. We entered the following mod- There was significant heterogeneity between studies: Q = 55.82, d.f. = 20, P < .001. All moderators except for Dose and Diagnosis were found to be significant (Table 3) . Oxytocin reduced feeding to a greater degree for solid, rather than liquid foods (eg, nutrient drinks,
Forest plot of studies measuring the effect of a single-dose of systemic oxytocin on energy intake over a 1-h measurement duration in animals. CI, confidence interval juice and smoothies). There was a greater inhibitory effect of oxytocin on feeding for males than females, when participants were full, rather than fasted, and when food was presented for a longer period of time (although the effect size was close to zero). There was a marginally significant effect such that oxytocin reduced feeding to a greater degree in obese participants. A greater dose of oxytocin was not associated with quantity of food consumption. There was significant residual heterogeneity after taking each moderator into account.
Residual heterogeneity for each moderator is reported in Table 3 .
Based on the difficulty of interpreting the results given such a range of significant moderators, we then proceeded to repeat the analysis including only studies that had measured the consumption of solid foods. Because all but one of the studies in the metaregression for solid foods included only female participants, the gender moderator was not included in this analysis.
Ten experiments with a total of 486 observations were included in the meta-regression for human studies measuring consumption of solid foods. Visual inspection of the Cook's plot did not reveal undue influence of any study (all values <0.7). The meta-regression for human studies isolated into the solid food condition found a marginally significant main effect of oxytocin on food consumption with a small effect size (d = −0.25, SE = 0.132, P = .055, 95% CI = −0.510 to 0.006). The forest plot for this metaregression is shown in Figure 7 . None of the included moderators were significant (Table 4 ). There was significant residual heterogeneity after controlling for Gender, Fasted or Full condition, Duration of Administration and Dose. Although the diagnosis moderator was not significant (QM 3 = 3.01, P = .391), there was no longer significant residual heterogeneity after controlling for diagnosis (QE 6 = 12.18, P = .058). 
| Publication bias
The funnel plots associated with each meta-regression are shown in the Supporting information (Figures S1-S5 ). The funnel plots indicated that most studies had a moderate degree of precision, with a broad range of effect sizes being reported. These findings do not suggest systematic publication bias towards papers with either a strong or weak effect size.
| Mediators and moderators of the anorexigenic effects of oxytocin
Among the studies included in the current systematic review, there were many factors that were found to moderate the effect of oxytocin on feeding in some studies, including sex of the animal, pregnancy, dose, method of administration, setting and dietary factors.
Because not all studies met criteria for inclusion in one of the metaregressions, the results reported below focus on a sample of other identified studies that examined a moderating or mediating factor in a controlled experimental design.
| Sex differences
Several studies investigated sex differences with respect to the effects of oxytocin on feeding. Bjorkstrand and Uvnas-Moberg 17 found that i.c.v. injection of oxytocin (5 μg) increased feeding in female but not male rats. Conversely, Zhou et al. 18 found that oxytocin induced a greater reduction in feeding in female rats, with anorexigenic effects being observed using doses of oxytocin of 0.3, 1 and 3 mg kg -1 , whereas only the dose of 3 mg kg -1 was effective at reducing feeding in males. To further add to these mixed findings, Benelli et al. 19 failed to find any differences in male versus female rat responses to the effects of oxytocin on feeding. Previous studies have demonstrated that feeding varies across differing stages of the oestrous cycle in rodents, nonhuman primates and humans. [20] [21] [22] The feeding response to hunger-related hormones (including ghrelin) and neurosteroids also varies throughout different stages of the oestrous cycle in female rats. 23 It is recommended that future studies continue to investigate the extent to which oestrous cycle phase and fluctuations in ovarian hormones might influence the satiety response to oxytocin in female animal models. Thienel et al. 30 
| Pregnancy
Only one study 24 tested the effect of pregnancy as a moderator for the effect of oxytocin on feeding. This study identified that i.c.v. injection of oxytocin (1 μg) decreased feeding in virgin female rats over 1 hour of measurement, whereas it had no continued effect on feeding over 12 hours. However, a different pattern of effects was observed in pregnant rats, with the same dose of oxytocin exerting no effect on feeding over 1 hour, whereas it increased feeding over 12 hours. It was proposed that this may be a result of changes in the expression and binding affinity of central oxytocin receptors during pregnancy. differential sensitivity of the NTS and fourth ventricle to the anorexigenic effects of oxytocin therefore represents an interesting avenue for future research.
In another study examining the impact of injecting oxytocin into different regions of the central nervous system, Herisson et al. 27 demonstrated that doses of oxytocin of 1 and 3 μg injected directly into the nucleus accumbens core reduced both chow intake and the consumption of a 10% sucrose solution in male rats, whereas these inhibitory effects were not observed when the same dose was injected into the nucleus accumbens shell. The administration of oxytocin into the nucleus accumbens core was associated with increased Fos-immunoreactivity in both the nucleus accumbens core itself, as well as the paraventricular nucleus and supraoptic nucleus of the hypothalamus, comprising two regions dense in oxytocin neurones and receptors that are involved in feeding regulation. 28 These findings therefore support a potential role of the nucleus accumbens core in mediating the anorexigenic effects of oxytocin, which does not extend to the nucleus accumbens shell.
One point to note is that most studies administered high supraphysiological doses of oxytocin. Although these doses may be required in the case of peripheral administration to increase the chances that some oxytocin will cross the blood-brain barrier, it should be noted that these findings may reflect partial oxytocin binding with vasopressin receptors at high doses that would not occur at physiological levels.
| Social setting
The social conditions in which animals were housed were also found to impact the effect of oxytocin on feeding. Grippo et al. 29 reported that isolating female prairie voles from litter-mates resulted in a decrease in sucrose intake over a period of two weeks in a placebo condition, although this effect was prevented by oxytocin. In the cohoused group of prairie voles, however, there were no changes in sucrose intake over time, nor were there any differences between the oxytocin and placebo conditions. Additionally, Herisson et al. 27 found that central oxytocin administration reduced food and sucrose intake in individually-housed male rats, whereas neither of these effects was observed in male rats allowed some social contact with a conspecific. Both of these studies highlight the potential for social housing to prevent oxytocinergic reductions in feeding that would otherwise occur in isolated social settings.
| Dietary factors
Finally, diet-induced obesity was also identified as an important moderating factor for the effects of oxytocin on feeding in both animals and humans. 8, [30] [31] [32] [33] [34] On the whole, direct comparisons of lean animals consuming standard chow with diet-induced obese animals consuming high-fat diets found that oxytocin had more consistent inhibitory effects on feeding in the dietary-induced obese animals. 8, 31 Blevins et al. 31 showed that this moderating effect persists in high-fat dietfed rats, even when matched for body mass and adiposity with chow-fed controls, thus indicating that this moderating effect may be more attributable to the fat-content of the diet of an animal than to body composition.
| D ISCUSS I ON
The present review aimed to identify published and unpublished studies testing the effects of exogenous oxytocin on energy intake in wild-type animals and humans, where oxytocin was administered in isolation from other active drugs and surgery. The systematic review and meta-analysis revealed a robust inhibitory effect of oxytocin on energy intake when administered as a single dose in animals, regardless of whether it was administered via a central or peripheral route.
Additionally, although several individual experiments did show a continued inhibitory effect of oxytocin for periods of two or more weeks in rats and mice, 8, 31, [35] [36] [37] [38] [39] when final-day energy intake was compared between placebo and oxytocin conditions in the quantitative meta-analysis, this inhibitory effect did not hold.
The human studies did not find a main effect of oxytocin on energy intake; however, there was a trend towards a decrease in the consumption of solid foods induced by oxytocin. Additionally, oxytocin had a stronger inhibitory effect on energy intake in male participants, in obese participants, and when participants completed the experiment in the full condition (rather than fasted condition). The specific finding that oxytocin reduced feeding to a greater degree in obese humans 30 is consistent with findings from animal studies that have also indicated a greater anorexigenic effect in diet-induced obese mice and rats. 8 The moderating effect of liquid versus solid foods was unexpected amongst the human studies, particularly given previous animal research demonstrating the inhibitory effect of oxytocin on the consumption of palatable liquid solutions. 27, 40, 41 The mechanism driving the difference between the effect of oxytocin on liquid and solid foods is unclear. One hypothesis is that oxytocin may reduce gastric motility, thus contributing to the sensation of satiety because solid food remains in the gut for a longer period of time. This hypothesis is supported by research demonstrating that oxytocin can reduce gastric motility in rats [42] [43] [44] [45] and mice. 46 However, Borg et al. 47 reported evidence suggesting that oxytocin does not affect gastric emptying rate in humans following consumption of a liquid meal. Further research would be useful to test this hypothesis as it pertains to solid foods, as well as to further investigate the reasons for the greater inhibitory effect of oxytocin for solid versus liquid consumption in humans.
The pattern for the inhibitory effect of oxytocin on feeding to decrease over time was reflected in a significant moderator analysis carried out for the meta-regression of studies that administered systemic oxytocin to animals chronically over time. This meta-regression and the meta-regression for human studies were also significantly moderated by sex, such that the effects of oxytocin on reducing feeding were significantly greater for male animals. This overall moderating effect of sex across studies included in the meta-regression is interesting to observe given the highly mixed findings regarding sex differences reported in individual studies. [17] [18] [19] A greater density of oxytocin receptors has previously been reported within the spinal cord and ventromedial hypothalamus of male rats, 48 which may potentially explain the greater sensitivity to the anorexigenic effects of oxytocin in males. However, the activity of oxytocin and oxytocin receptors also varies across stages of the follicular cycle in female prairie voles. 49 Furthermore, levels of endogenous plasma oxytocin vary across stages of the menstrual cycle in humans. 50 One can hypothesise that this natural variation may moderate the effects of exogenously-administered oxytocin. Variation in the follicular stage at which oxytocin was administered to female animals may therefore partially account for the mixed findings reported for feeding effects in previous studies. It would be useful to specifically investigate variation in the effect of oxytocin on feeding across different phases of the follicular cycle, as well as associated variation in plasma levels of other hormones (eg, oestrogen).
In terms of the mechanisms explaining the greater effect of oxytocin in obese animals and humans, oxytocin receptors exhibit a higher-affinity binding state in the presence of cholesterol. 51 Therefore, it may be that a greater fat-and cholesterol-rich diet at least partially explains the greater anorexigenic effects of oxytocin observed in obese animals and humans.
The mechanisms and neural circuits explaining the overall anorexigenic effects of oxytocin are still somewhat uncertain.
Oxytocin is known to mediate the anorexigenic effects of cholecystokinin (CCK), which acts on oxytocin neurones via vagal afferents from the gut. 1 This finding has received further support from research demonstrating that injections of oxytocin into the third cerebral ventricle enhance the anorexigenic effects of low doses of CCK-8, 31 whereas, conversely, pre-treatment of an oxytocin receptor antagonist into the fourth ventricle suppresses the anorexigenic effects of CCK. 52, 53 In addition to this role mediating the effects of CCK, oxytocin has also been implicated in mediating the inhibitory effects of leptin 54, 55 and nesfatin-1 56 on food intake. The downstream mechanisms by which oxytocin impacts on feeding, however, are less certain.
It is likely that central and peripheral oxytocin exert effects of feeding via different mechanisms. Previous research has identified that only approximately 0.002% of peripheral oxytocin crosses the blood-brain barrier, where it might access central receptors. 57 However, the extent to which peripheral oxytocin exerts its effects via central versus peripheral receptors, such as those in the gut, 58 may be species-dependent. In mice, the literature supports a role for vagal afferent nerves in mediating the anorexigenic effect of peripheral oxytocin. 59, 60 This interpretation draws support from research showing that oxytocin receptors are expressed in the nodose ganglion of the vagus nerve, 59 as well as further research that
has gone on to demonstrate that vagotomy results in an attenuation of the anorexigenic effect of peripherally-administered oxytocin in mice. 60 In rats, however, Ho et al. 26 showed that hindbrain receptors accessed via the fourth ventricle are predominantly responsible for mediating the inhibitory effects of peripheral oxytocin on feeding. Further research clarifying which pathway(s) predominate this mediating effect in primates and humans would be useful.
Brain nuclei including the paraventricular nucleus, NTS and arcuate nucleus were implicated as being potentially relevant in mediating the effects of oxytocin on feeding. 25, [60] [61] [62] [63] It has also been proposed that oxytocin may exert inhibitory effects on energy intake via a physiological pathway mediated by reward-based mechanisms. 65 This hypothesis is supported by the high density of oxytocin receptors along the pathways connecting the nucleus accumbens and ventral tegmental area, [66] [67] [68] which are two regions known to be highly involved with processing food rewards. 69 Additionally, oxytocin injected directly into the nucleus accumbens has been found to reduce methamphetamine-induced place preference 70 and to prevent relapse to methamphetamineseeking behavior after extinction. 71 Taken together, these findings highlight the ability for oxytocin to disrupt reward-related processing in these regions, which may additionally extend to suppressing reward-based feeding behaviour. This hypothesis, if true, may also explain the stronger effects of oxytocin in reducing hedonic, as opposed to hunger-driven, feeding in human studies. 30, 72, 73 Further research in animals and humans would be useful to test this hypothesis and clarify the precise mechanisms of the acute action of oxytocin on energy intake.
The confirmation of the anorexigenic effects of oxytocin when administered as a single dose echoes conventional understanding, at the same time as highlighting the limits of this effect, such as the reverse (orexigenic) effect observed in pregnancy 24 and the observations reported when socially-housed animals subsequently undergo separation from litter-mates. 29 The null findings revealed in the meta-analysis testing the chronic effects of oxytocin on feeding are disappointing in the context of potential hopes for developing oxytocin supplementation as a new treatment for binge-type eating disorders in humans, and conflict with individual studies that have reported the persistence of the anorexigenic effects of oxytocin over two to three weeks of measurement in rats and mice, 8, 31, 36, 38, 74, 75 as well as for two weeks post-treatment in rhesus monkeys. 39 It may be the case that a regime of intermittent oxytocin administration would result in the same anorexigenic effects observed within the course of a single experimental administration, without resulting in the same degree of receptor adaptations. Future research testing different temporal regimes of oxytocin administration is recommended to test this hypothesis.
The diminishing effects of oxytocin are in keeping with the results arising from individual studies making use of the repeated administration of oxytocin 8, 31, 33, 36, 37 or an oxytocin agonist. 76 These findings are also in accordance with social experiments showing that the anxiolytic effects of oxytocin disappear or reverse over time. 77 Peters et al. 77 found that the reversal of acute anxiolytic effects over chronic dosing was associated with a concurrent reduction in oxytocin receptor binding. Indeed, previous work has shown that oxytocin receptor binding can be reduced by as much as 50% over ten days of chronic administration, driven largely by down-regulation of the oxytocin receptor. 78 It is therefore likely that this reduced binding potential may explain the dampening of the effects of oxytocin on feeding.
The null findings generated from the meta-regressions of chronically-administered oxytocin studies should be interpreted with some degree of caution. Although the final-day analyses used for the meta-regressions maximised the number of commensurable studies eligible for inclusion, it may be that noise in the data on the final day data masked smaller effects identified by studies that compared average consumption across several days. It should also be noted that the scope of the present review is limited to the effects of oxytocin on energy intake alone, and that the effects of oxytocin on other metabolic parameters deterring obesity (eg, lipolysis, brown adipose tissue thermogenesis and energy expenditure) may persist with chronic administration. 74 The limitations of the present review include some inherent drawbacks of the methodology chosen for the meta-regressions. We aimed to reach a compromise between maximising the homogeneity of studies included in each meta-regression, at the same time as also including the maximum number of experiments. The choice to include only single-dose studies that measured the effects of oxytocin over one hour of feeding therefore constrained these metaregressions to a reasonable scope and similar effect size. Differences in the exact location of administration and animals included in each experiment, however, may have added to the heterogeneity of effect size observed across studies. Furthermore, the present systematic review did not include findings from non-wild-type animals (eg, Sim-haploinsufficient rats and mice) or animals whose nervous systems were altered by surgery or direct stimulation. Therefore, although the present findings reveal the effects of exogenous oxytocin in wild-type animals, it should be noted that there are further findings reflecting the implication of oxytocin on feeding that were not included within the scope of the present review.
Regarding the clinical implications of these findings, it is particularly encouraging to have observed that the anorexigenic effects of oxytocin were stronger for populations that suffer from over-eating and binge-eating. These findings suggest that, in the short term, oxytocin may reduce the likelihood of binge-eating and overeating for populations with obesity, bulimia nervosa and binge-eating disorders. However, the null findings from the meta-regressions of chronic animal studies cast doubt on the persistence of the acute effects of oxytocin. Testing different dosing schedules of oxytocin would be useful for identifying a potential frequency and dose of administration that maintains the beneficial effects of oxytocin over time, without resulting in a reduction of receptor binding.
In conclusion, the present systematic review has confirmed the anorexigenic effect of a single dose of oxytocin in animals first documented by the Arletti laboratory, 3 at the same time as demonstrating that this anorexigenic effect does not persist throughout chronic
dosing. There was a trend for intranasal oxytocin to reduce feeding in humans, and this effect was stronger for individuals with obesity, bulimia nervosa, and binge-eating disorders. Future research is needed to further clarify the mechanisms responsible for these effects, and whether different dosing schedules might prevent their attenuation with chronic administration.
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